Please login to the form below

Not currently logged in
Email:
Password:

Sir Philip Hampton set to be new GSK chair

RBS chairman to replace Sir Christopher Gent

philip hampton gskGlaxoSmithKline (GSK) is set to name the Royal Bank of Scotland's (RBS) Sir Philip Hampton as the company's new chairman, according to local reports.

Several UK media outlets have published stories suggesting GSK will this week officially announce Sir Philip (pictured) as chairman-designate, replacing Sir Christopher Gent when he steps down in 2015.

The news come at a time of pressure for GSK after the company was recently hit with a $487m fine for illegal marketing practices in China.

Sir Philip has served as chairman of the board at RBS since 2009, overseeing the company during a time of global economic collapse.

He has experience in a wide variety of industries, with previous roles including chairman of Sainsbury's and as group finance directory at Lloyds TSB, BT Group, BG Group, British Gas and British Steel.

He is also a former chairman of UK Financial Investments Limited, which manages the UK Government's shareholdings in banks.


25th September 2014

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics